Suzhou Zelgen Biopharmaceuticals Co.,ltd

This early-stage study aims to check the safety of a new drug called ZG006 when given alongside standard immunotherapy drugs for people with extensive small-cell lung cancer. It will involve about 100 adults who have not yet received treatment for this aggressive cancer. The main…

This study is testing a new drug called ZGGS34 for people with advanced solid tumors that have stopped responding to standard treatments. The first part checks how safe different doses are, while the second part looks at whether the drug helps shrink tumors in people whose cancer…